{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:40:26Z","timestamp":1792701626446,"version":"4.5.0"},"reference-count":85,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2021,1,12]]},"DOI":"10.1001\/jama.2020.21899","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T07:00:01Z","timestamp":1610607601000},"page":"164","source":"Crossref","is-referenced-by-count":719,"title":["Glaucoma in Adults\u2014Screening, Diagnosis, and Management"],"prefix":"10.1001","volume":"325","author":[{"given":"Joshua D.","family":"Stein","sequence":"first","affiliation":[{"name":"W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"},{"name":"Center for Eye Policy and Innovation, University of Michigan, Ann Arbor"},{"name":"Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Khawaja","sequence":"additional","affiliation":[{"name":"NIHR Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer S.","family":"Weizer","sequence":"additional","affiliation":[{"name":"W.K. Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"11","key":"jrv200016r2","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040.","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"jrv200016r3","doi-asserted-by":"crossref","first-page":"e888","DOI":"10.1016\/S2214-109X(17)30293-0","article-title":"Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment.","volume":"5","author":"Bourne","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"20","key":"jrv200016r4","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1056\/NEJM199111143252005","article-title":"Undertreatment of glaucoma among black Americans.","volume":"325","author":"Javitt","year":"1991","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv200016r5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0039-6257(03)00028-6","article-title":"Primary open-angle glaucoma in blacks: a review.","volume":"48","author":"Racette","year":"2003","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"jrv200016r6","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ophtha.2010.10.024","article-title":"Differences in rates of glaucoma among Asian Americans and other racial groups, and among various Asian ethnic groups.","volume":"118","author":"Stein","year":"2011","journal-title":"Ophthalmology"},{"issue":"19","key":"jrv200016r7","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.2013.5099","article-title":"Do findings on routine examination identify patients at risk for primary open-angle glaucoma?","volume":"309","author":"Hollands","year":"2013","journal-title":"JAMA"},{"issue":"18","key":"jrv200016r8","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1001\/jama.2014.3192","article-title":"The pathophysiology and treatment of glaucoma: a review.","volume":"311","author":"Weinreb","year":"2014","journal-title":"JAMA"},{"issue":"8","key":"jrv200016r9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1001\/archopht.1991.01080080050026","article-title":"Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans: the Baltimore Eye Survey.","volume":"109","author":"Sommer","year":"1991","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"jrv200016r10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/archopht.119.12.1819","article-title":"The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER.","volume":"119","author":"Quigley","year":"2001","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"jrv200016r11","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.ajo.2007.09.013","article-title":"Factors associated with undiagnosed open-angle glaucoma: the Thessaloniki Eye Study.","volume":"145","author":"Topouzis","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"jrv200016r12","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2019-315330","article-title":"Glaucoma in the Northern Ireland Cohort for the Longitudinal Study of Ageing (NICOLA).","author":"McCann","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"jrv200016r13","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ajo.2014.08.023","article-title":"Burden of undetected and untreated glaucoma in the United States.","volume":"158","author":"Shaikh","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"jrv200016r14","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jamaophthalmol.2015.1478","article-title":"Prevalence, risk factors, and visual features of undiagnosed glaucoma.","volume":"133","author":"Chua","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"jrv200016r15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.ophtha.2012.11.043","article-title":"How does glaucoma look?","volume":"120","author":"Crabb","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"jrv200016r16","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1167\/iovs.12-10618","article-title":"Difficulty with out-loud and silent reading in glaucoma.","volume":"54","author":"Ramulu","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"jrv200016r17","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.ophtha.2008.06.023","article-title":"The utility of symptoms in identification of primary angle-closure in a high-risk population.","volume":"115","author":"Ong","year":"2008","journal-title":"Ophthalmology"},{"key":"jrv200016r18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.exer.2017.02.005","article-title":"Biomechanical aspects of axonal damage in glaucoma: a brief review.","volume":"157","author":"Stowell","year":"2017","journal-title":"Exp Eye Res"},{"issue":"4","key":"jrv200016r19","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma.","volume":"21","author":"Flammer","year":"2002","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"jrv200016r20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.23926","article-title":"Is there a link between open-angle glaucoma and dementia","volume":"74","author":"Helmer","year":"2013","journal-title":"Ann Neurol"},{"issue":"10","key":"jrv200016r21","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1001\/jamaneurol.2018.1578","article-title":"Association of retinal nerve fiber layer thinning with current and future cognitive decline.","volume":"75","author":"Ko","year":"2018","journal-title":"JAMA Neurol"},{"issue":"9","key":"jrv200016r22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.3931","article-title":"Classification of common human diseases derived from shared genetic and environmental determinants.","volume":"49","author":"Wang","year":"2017","journal-title":"Nat Genet"},{"issue":"12","key":"jrv200016r23","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/archopht.116.12.1640","article-title":"Genetic risk of primary open-angle glaucoma: population-based familial aggregation study.","volume":"116","author":"Wolfs","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"jrv200016r24","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2019.107702","article-title":"Mendelian genes in primary open angle glaucoma.","volume":"186","author":"Sears","year":"2019","journal-title":"Exp Eye Res"},{"issue":"3","key":"jrv200016r25","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ophtha.2016.11.011","article-title":"Myocilin predictive genetic testing for primary open-angle glaucoma leads to early identification of at-risk individuals.","volume":"124","author":"Souzeau","year":"2017","journal-title":"Ophthalmology"},{"issue":"42","key":"jrv200016r26","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1706193114","article-title":"CRISPR-Cas9-based treatment of myocilin-associated glaucoma.","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"jrv200016r27","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41588-018-0126-8","article-title":"Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma.","volume":"50","author":"Khawaja","year":"2018","journal-title":"Nat Genet"},{"issue":"2","key":"jrv200016r28","first-page":"438","article-title":"New insights into the genetics of primary open-angle glaucoma based on meta-analyses of intraocular pressure and optic disc characteristics.","volume":"26","author":"Springelkamp","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"1","key":"jrv200016r29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41433-019-0632-7","article-title":"Clinical implications of recent advances in primary open-angle glaucoma genetics.","volume":"34","author":"Choquet","year":"2020","journal-title":"Eye (Lond)"},{"issue":"12","key":"jrv200016r30","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.ophtha.2016.08.036","article-title":"Glaucoma risk alleles in the Ocular Hypertension Treatment Study.","volume":"123","author":"Scheetz","year":"2016","journal-title":"Ophthalmology"},{"issue":"1","key":"jrv200016r31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.survophthal.2009.03.006","article-title":"Glaucoma and systemic diseases.","volume":"55","author":"Salim","year":"2010","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"jrv200016r34","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1167\/iovs.08-2956","article-title":"Blood pressure, perfusion pressure, and open-angle glaucoma.","volume":"51","author":"Memarzadeh","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"jrv200016r35","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/IJG.0000000000000981","article-title":"New recommendations for the treatment of systemic hypertension and their potential implications for glaucoma management.","volume":"27","author":"De Moraes","year":"2018","journal-title":"J Glaucoma"},{"issue":"1","key":"jrv200016r36","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ophtha.2003.04.004","article-title":"Topiramate-associated acute, bilateral, secondary angle-closure glaucoma.","volume":"111","author":"Fraunfelder","year":"2004","journal-title":"Ophthalmology"},{"key":"jrv200016r37","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.12659\/MSM.895897","article-title":"Effects of use of a continuous positive airway pressure device on glaucoma.","volume":"21","author":"Ulusoy","year":"2015","journal-title":"Med Sci Monit"},{"issue":"10","key":"jrv200016r38","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1016\/j.ophtha.2012.04.029","article-title":"The relationship between statin use and open-angle glaucoma.","volume":"119","author":"Stein","year":"2012","journal-title":"Ophthalmology"},{"issue":"6","key":"jrv200016r39","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1167\/iovs.15-18595","article-title":"The effect of statins on intraocular pressure and on the incidence and progression of glaucoma.","volume":"57","author":"McCann","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"jrv200016r40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.7326\/0003-4819-158-4-201302190-00008","article-title":"Comparative effectiveness of treatments for open-angle glaucoma: a systematic review for the US Preventive Services Task Force.","volume":"158","author":"Boland","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"jrv200016r41","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ophtha.2015.10.053","article-title":"Primary open-angle glaucoma preferred practice pattern guidelines.","volume":"123","author":"Prum","year":"2016","journal-title":"Ophthalmology."},{"key":"jrv200016r42","article-title":"Accuracy of Kalman filtering in forecasting visual field and intraocular pressure trajectory in patients with ocular hypertension.","author":"Garcia","journal-title":"JAMA Ophthalmol"},{"key":"jrv200016r43","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ajo.2018.10.012","article-title":"Using Kalman filtering to forecast disease trajectory for patients with normal tension glaucoma.","volume":"199","author":"Garcia","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"jrv200016r44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1167\/iovs.18-25568","article-title":"An artificial intelligence approach to detect visual field progression in glaucoma based on spatial pattern analysis.","volume":"60","author":"Wang","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"jrv200016r45","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ophtha.2017.10.033","article-title":"Personalized prediction of glaucoma progression under different target intraocular pressure levels using filtered forecasting methods.","volume":"125","author":"Kazemian","year":"2018","journal-title":"Ophthalmology"},{"issue":"6","key":"jrv200016r46","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"jrv200016r49","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.ophtha.2007.03.016","article-title":"Predictors of long-term progression in the early manifest glaucoma trial.","volume":"114","author":"Leske","year":"2007","journal-title":"Ophthalmology"},{"issue":"2","key":"jrv200016r50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ophtha.2008.08.051","article-title":"Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.","volume":"116","author":"Musch","year":"2009","journal-title":"Ophthalmology"},{"issue":"2","key":"jrv200016r51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00055735-200304000-00006","article-title":"Collaborative normal tension glaucoma study.","volume":"14","author":"Anderson","year":"2003","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"jrv200016r52","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ophtha.2012.07.028","article-title":"The United Kingdom Glaucoma Treatment Study.","volume":"120","author":"Garway-Heath","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"jrv200016r53","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures.","volume":"126","author":"Collaborative Normal-Tension Glaucoma Study Group","year":"1998","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"jrv200016r54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS), 7: the relationship between control of intraocular pressure and visual field deterioration.","volume":"130","author":"The AGIS Investigators","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"11","key":"jrv200016r55","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0161-6420(01)00873-9","article-title":"Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery.","volume":"108","author":"Lichter","year":"2001","journal-title":"Ophthalmology"},{"issue":"6","key":"jrv200016r56","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"jrv200016r57","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression.","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"jrv200016r58","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/ICU.0b013e3283360b68","article-title":"Review of results from the Tube Versus Trabeculectomy study.","volume":"21","author":"Gedde","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"jrv200016r59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajo.2011.10.024","article-title":"Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.","volume":"153","author":"Gedde","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"10052","key":"jrv200016r60","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(16)30956-4","article-title":"Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE).","volume":"388","author":"Azuara-Blanco","year":"2016","journal-title":"Lancet"},{"issue":"10180","key":"jrv200016r61","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT).","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet"},{"issue":"10181","key":"jrv200016r62","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/S0140-6736(18)32607-2","article-title":"Laser peripheral iridotomy for the prevention of angle closure.","volume":"393","author":"He","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"jrv200016r63","first-page":"333","article-title":"Treatment outcomes in the Primary Tube Versus Trabeculectomy Study after 3 years of Follow-up.","volume":"127","author":"Gedde","year":"2020"},{"issue":"2","key":"jrv200016r64","article-title":"Glaucoma.","volume":"325","author":"Zuccotti","year":"2021","journal-title":"JAMA"},{"issue":"6","key":"jrv200016r65","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/ageing\/afl113","article-title":"Drops and falls.","volume":"35","author":"Spratt","year":"2006","journal-title":"Age Ageing"},{"issue":"2","key":"jrv200016r66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/IJG.0b013e3181d12e39","article-title":"American Glaucoma Society Position Statement: Marijuana and the Treatment of Glaucoma.","volume":"19","author":"Jampel","year":"2010","journal-title":"J Glaucoma"},{"key":"jrv200016r68","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.survophthal.2008.08.002","article-title":"Adherence and persistence with glaucoma therapy.","volume":"53","author":"Schwartz","year":"2008","journal-title":"Surv Ophthalmol"},{"issue":"4-5","key":"jrv200016r69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/17469899.2019.1635456","article-title":"Medication adherence in patients with ocular hypertension or glaucoma","volume":"14","author":"Robin","year":"2019","journal-title":"Expert Review of Ophthalmology"},{"issue":"2","key":"jrv200016r70","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40265-019-01248-0","article-title":"24-Month phase i\/ii clinical trial of bimatoprost sustained-release implant (Bimatoprost SR) in glaucoma patients.","volume":"80","author":"Craven","year":"2020","journal-title":"Drugs"},{"key":"jrv200016r71","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s40814-018-0320-6","article-title":"Personalized behavior change program for glaucoma patients with poor adherence: a pilot interventional cohort study with a pre-post design.","volume":"4","author":"Newman-Casey","year":"2018","journal-title":"Pilot Feasibility Stud"},{"issue":"2","key":"jrv200016r72","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/ICU.0b013e328086aebf","article-title":"Mechanisms of action and efficacy of argon laser trabeculoplasty and selective laser trabeculoplasty.","volume":"18","author":"Stein","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"issue":"1","key":"jrv200016r73","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40123-017-0082-x","article-title":"A review of selective laser trabeculoplasty: recent findings and current perspectives.","volume":"6","author":"Zhou","year":"2017","journal-title":"Ophthalmol Ther"},{"issue":"4","key":"jrv200016r74","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archophthalmol.2011.2727","article-title":"Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma.","volume":"130","author":"Stein","year":"2012","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"jrv200016r75","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0002-9394(00)00538-9","article-title":"The Advanced Glaucoma Intervention Study (AGIS): 7. the relationship between control of intraocular pressure and visual field deterioration.","volume":"130","author":"The AGIS Investigators","year":"2000","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"jrv200016r76","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/aos.14125","article-title":"Efficacy and safety of transscleral cyclophotocoagulation in Swedish glaucoma patients.","volume":"97","author":"Rasmuson","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"jrv200016r77","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.survophthal.2017.01.011","article-title":"Combined endocyclophotocoagulation and phacoemulsification in the management of moderate glaucoma.","volume":"62","author":"Rathi","year":"2017","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"jrv200016r78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ogla.2019.12.003","article-title":"American Glaucoma Society Position Paper: Microinvasive Glaucoma Surgery.","volume":"3","author":"Fellman","year":"2020","journal-title":"Ophthalmol Glaucoma"},{"issue":"1","key":"jrv200016r79","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ophtha.2018.05.012","article-title":"A schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study.","volume":"126","author":"Samuelson","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"jrv200016r80","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ophtha.2019.04.034","article-title":"A prospective randomized trial comparing Hydrus and iStent microinvasive glaucoma surgery implants for standalone treatment of open-angle glaucoma: the COMPARE Study.","volume":"127","author":"Ahmed","year":"2020","journal-title":"Ophthalmology"},{"key":"jrv200016r81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/OPTH.S239772","article-title":"Prospective studies of minimally invasive glaucoma surgeries: systematic review and quality assessment.","volume":"14","author":"Rosdahl","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"7","key":"jrv200016r82","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.ophtha.2018.01.015","article-title":"Laser peripheral iridotomy in primary angle closure: a report by the American Academy of Ophthalmology.","volume":"125","author":"Radhakrishnan","year":"2018","journal-title":"Ophthalmology"},{"issue":"1","key":"jrv200016r83","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ophtha.2013.09.003","article-title":"Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota.","volume":"121","author":"Malihi","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"jrv200016r84","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/ICU.0000000000000552","article-title":"Artificial intelligence in glaucoma.","volume":"30","author":"Zheng","year":"2019","journal-title":"Curr Opin Ophthalmol"},{"issue":"17","key":"jrv200016r85","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1001\/jama.2019.16161","article-title":"Association of genetic variants with primary open-angle glaucoma among individuals with African ancestry.","volume":"322","author":"Hauser","year":"2019","journal-title":"JAMA"},{"key":"jrv200016r1","unstructured":"National Eye Institute. Glaucoma awareness can help save vision for millions. Published December 22, 2015. Accessed December 20, 2020.? https:\/\/nei.nih.gov\/about\/news-and-events\/news\/glaucoma-awareness-can-help-save-vision-millions"},{"key":"jrv200016r32","unstructured":"Gamell? LS and Chen? BH. Glaucoma Today website. Glaucoma associated with systemic disease. Published November 2013. Accessed October 6, 2020.? https:\/\/glaucomatoday.com\/articles\/2013-nov-dec\/glaucoma-associated-with-systemic-disease"},{"key":"jrv200016r33","unstructured":"Achiron? A,?Sharif? N,?Haddad? F.? American Academy of Ophthalmology EyeWiki website. Drug-induced acute angle closure glaucoma. Page modified on November 8, 2019. Accessed October 4, 2020.? https:\/\/eyewiki.aao.org\/Drug-induced_Acute_Angle_Closure_Glaucoma"},{"key":"jrv200016r47","unstructured":"Ertel? MK, Aref? AA, Akkara? JD, Seibold? LK, Fern\u00e1ndez? MAM, Tabernero? SS. American Academy of Ophthalmology EyeWiki website. Clinical trials in glaucoma. Published May 19, 2020. Accessed September 24, 2019.? https:\/\/eyewiki.aao.org\/Clinical_Trials_in_Glaucoma"},{"key":"jrv200016r48","unstructured":"Washington University School of Medicine in St Louis. Ocular Hypertension Treatment Study (OHTS) risk calculator. Accessed June 14, 2020.? https:\/\/ohts.wustl.edu\/risk\/"},{"key":"jrv200016r67","unstructured":"AAO Complementary Therapy Task Force; Hoskins Center for Quality Eye Care. American Academy of Ophthalmology ONE Network website. Marijuana in the Treatment of Glaucoma CTA\u20142014. Published June 2014. Accessed April 20, 2020. https:\/\/www.aao.org\/complimentary-therapy-assessment\/marijuana-in-treatment-of-glaucoma-cta--may-2003"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2774838\/jama_stein_2021_rv_200016_1610384407.60625.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T16:52:33Z","timestamp":1697561553000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2774838"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":85,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,12]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2020.21899","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,12]]}}}